AI Science Tracker
EN

Panzhihua Central Hospital

1 discovery from 2026

Discoveries

A retrospective model predicts levetiracetam response in pediatric epilepsy

Source check: Source checked. Not independent scientific confirmation.

Finding: The retrospective study analyzed 346 pediatric patients and reports model performance and feature associations. The authors describe associations as hypothesis-generating; prospective clinical utility and benefit from model-guided treatment are not established.

Technology: XGBoost combined therapeutic drug monitoring measurements and ABCB1 genotype to predict treatment response; SHAP was used to interpret model features.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
XGBoost combined therapeutic drug monitoring measurements and ABCB1 genotype to predict treatment response; SHAP was used to interpret model features.
Test and result
The retrospective study analyzed 346 pediatric patients and reports model performance and feature associations.
Limitation / still unknown
The authors describe associations as hypothesis-generating; prospective clinical utility and benefit from model-guided treatment are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1914546/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.